CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 94 entries

View as:

Early Diabetes Intervention Program

Phase: N/A Priority: Normal

NCT ID: NCT01470937 Org: User:

Start: 02/28/98 End: 09/30/04 Due: 09/30/05

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Phase: N/A Priority: Normal

NCT ID: NCT00198081 Org: User:

Start: 09/30/05 End: 04/30/12 Due: 04/30/13

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00004258 Org: User:

Start: 12/31/99 End: 09/30/01 Due: 09/30/02

Using Informatics to Enhance Care of Older Emergency Department Patients

Phase: N/A Priority: Normal

NCT ID: NCT00297869 Org: User:

Start: 01/31/05 End: 06/30/10 Due: 06/30/11

International SMA Patient Registry

Phase: N/A Priority: Normal

NCT ID: NCT00466349 Org: User:

Start: 05/31/86 End: 01/31/18 Due: 01/31/19

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00453180 Org: User:

Start: 03/31/07 End: 11/30/09 Due: 11/30/10

Assessment of Lung Structure and Function of Infants Born Prematurely

Phase: N/A Priority: Normal

NCT ID: NCT00422305 Org: User:

Start: 01/31/07 End: 01/31/19 Due: 01/31/20

Galantamine Augmentation of Escitalopram for Treatment of Depression

Phase: N/A Priority: Normal

NCT ID: NCT00423969 Org: User:

Start: 11/30/03 End: 09/30/05 Due: 09/30/06

Chromoendoscopy for Ulcerative Colitis Surveillance

Phase: N/A Priority: Normal

NCT ID: NCT00274209 Org: User:

Start: 12/31/05 End: 11/30/11 Due: 11/30/12

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00216281 Org: User:

Start: 09/30/05 End: 09/30/08 Due: 09/30/09

Parkinson's Research: The Organized Genetics Initiative

Phase: N/A Priority: Normal

NCT ID: NCT00086073 Org: User:

Start: 08/31/98 End: 01/31/11 Due: 01/31/12

Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT01348503 Org: User:

Start: 05/31/11 End: 03/31/14 Due: 03/31/15

A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients

Phase: N/A Priority: Normal

NCT ID: NCT00198094 Org: User:

Start: 12/31/03 End: 09/30/07 Due: 09/30/08

Assessment of Airway Obstruction in Infants With Lower Respiratory Infections

Phase: N/A Priority: Normal

NCT ID: NCT00435994 Org: User:

Start: 12/31/03 End: 12/31/12 Due: 12/31/13

Extending HIV Care Beyond the Rural Health Center

Phase: N/A Priority: Normal

NCT ID: NCT00371540 Org: User:

Start: 02/28/06 End: 04/30/08 Due: 04/30/09

The Role of Serotonin in Hot Flashes After Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00228943 Org: User:

Start: 07/31/05 End: 11/30/08 Due: 11/30/09

Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.

Phase: N/A Priority: Normal

NCT ID: NCT00355446 Org: User:

Start: 07/31/01 End: 10/31/04 Due: 10/31/05

Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00216294 Org: User:

Start: 02/28/05 End: 04/30/06 Due: 04/30/07

Nitric Oxide to Treat Pulmonary Embolism

Phase: N/A Priority: Normal

NCT ID: NCT01939301 Org: User:

Start: 10/31/13 End: 10/31/16 Due: 10/31/17

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00975975 Org: User:

Start: 09/30/09 End: 11/30/13 Due: 11/30/14

Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair

Phase: N/A Priority: Normal

NCT ID: NCT02036983 Org: User:

Start: 11/30/13 End: 08/31/15 Due: 08/31/16

A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00369889 Org: User:

Start: 08/31/06 End: 09/30/07 Due: 09/30/08

Treating the Endothelium to Restore Insulin Sensitivity

Phase: N/A Priority: Normal

NCT ID: NCT00402194 Org: User:

Start: 06/30/05 End: 03/31/12 Due: 03/31/13

Vitamin E for NASH Treatment in HIV Infected Individuals

Phase: N/A Priority: Normal

NCT ID: NCT03669133 Org: User:

Start: 10/01/19 End: 03/08/21 Due: 03/08/22

A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

Phase: N/A Priority: Normal

NCT ID: NCT00477542 Org: User:

Start: 05/31/07 End: 11/30/10 Due: 11/30/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Early Diabetes Intervention Program	NCT01470937	Indiana University School of Medicine	user2@example.com	None	1998-02-28	2004-09-30	2005-09-30	-	-	2025-07-14
Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)	NCT00198081	Indiana University School of Medicine	user2@example.com	None	2005-09-30	2012-04-30	2013-04-30	-	-	2025-07-14
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer	NCT00004258	Indiana University School of Medicine	user2@example.com	None	1999-12-31	2001-09-30	2002-09-30	-	-	2025-07-14
Using Informatics to Enhance Care of Older Emergency Department Patients	NCT00297869	Indiana University School of Medicine	user2@example.com	None	2005-01-31	2010-06-30	2011-06-30	-	-	2025-07-14
International SMA Patient Registry	NCT00466349	Indiana University School of Medicine	user2@example.com	None	1986-05-31	2018-01-31	2019-01-31	-	-	2025-07-14
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders	NCT00453180	Indiana University School of Medicine	user2@example.com	None	2007-03-31	2009-11-30	2010-11-30	-	-	2025-07-14
Assessment of Lung Structure and Function of Infants Born Prematurely	NCT00422305	Indiana University School of Medicine	user2@example.com	None	2007-01-31	2019-01-31	2020-01-31	-	-	2025-07-14
Galantamine Augmentation of Escitalopram for Treatment of Depression	NCT00423969	Indiana University School of Medicine	user2@example.com	None	2003-11-30	2005-09-30	2006-09-30	-	-	2025-07-14
Chromoendoscopy for Ulcerative Colitis Surveillance	NCT00274209	Indiana University School of Medicine	user2@example.com	None	2005-12-31	2011-11-30	2012-11-30	-	-	2025-07-14
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia	NCT00216281	Indiana University School of Medicine	user2@example.com	None	2005-09-30	2008-09-30	2009-09-30	-	-	2025-07-14
Parkinson's Research: The Organized Genetics Initiative	NCT00086073	Indiana University School of Medicine	user2@example.com	None	1998-08-31	2011-01-31	2012-01-31	-	-	2025-07-14
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma	NCT01348503	Indiana University School of Medicine	user2@example.com	None	2011-05-31	2014-03-31	2015-03-31	-	-	2025-07-14
A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients	NCT00198094	Indiana University School of Medicine	user2@example.com	None	2003-12-31	2007-09-30	2008-09-30	-	-	2025-07-14
Assessment of Airway Obstruction in Infants With Lower Respiratory Infections	NCT00435994	Indiana University School of Medicine	user2@example.com	None	2003-12-31	2012-12-31	2013-12-31	-	-	2025-07-14
Extending HIV Care Beyond the Rural Health Center	NCT00371540	Indiana University School of Medicine	user2@example.com	None	2006-02-28	2008-04-30	2009-04-30	-	-	2025-07-14
The Role of Serotonin in Hot Flashes After Breast Cancer	NCT00228943	Indiana University School of Medicine	user2@example.com	None	2005-07-31	2008-11-30	2009-11-30	-	-	2025-07-14
Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.	NCT00355446	Indiana University School of Medicine	user2@example.com	None	2001-07-31	2004-10-31	2005-10-31	-	-	2025-07-14
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder	NCT00216294	Indiana University School of Medicine	user2@example.com	None	2005-02-28	2006-04-30	2007-04-30	-	-	2025-07-14
Nitric Oxide to Treat Pulmonary Embolism	NCT01939301	Indiana University School of Medicine	user2@example.com	None	2013-10-31	2016-10-31	2017-10-31	-	-	2025-07-14
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer	NCT00975975	Indiana University School of Medicine	user2@example.com	None	2009-09-30	2013-11-30	2014-11-30	-	-	2025-07-14
Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair	NCT02036983	Indiana University School of Medicine	user2@example.com	None	2013-11-30	2015-08-31	2016-08-31	-	-	2025-07-14
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer	NCT00369889	Indiana University School of Medicine	user2@example.com	None	2006-08-31	2007-09-30	2008-09-30	-	-	2025-07-14
Treating the Endothelium to Restore Insulin Sensitivity	NCT00402194	Indiana University School of Medicine	user2@example.com	None	2005-06-30	2012-03-31	2013-03-31	-	-	2025-07-14
Vitamin E for NASH Treatment in HIV Infected Individuals	NCT03669133	Indiana University School of Medicine	user2@example.com	None	2019-10-01	2021-03-08	2022-03-08	-	-	2025-07-14
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT	NCT00477542	Indiana University School of Medicine	user2@example.com	None	2007-05-31	2010-11-30	2011-11-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance